British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

AstraZeneca has unveiled plans to invest £2bn in Beijing months after Chinese authorities detained the company’s local boss ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...

Foreign CEOs, including Tim Cook of Apple, as well as Republican Sen. Steve Daines are in Beijing for the two-day China ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

Astrazeneca plc is investing heavily in China, signing two R&D deals, worth up to about $8 billion in up-front payments and ...

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

The pharmaceutical firm expects its workforce in Beijing to grow to 1,700 employees and is launching a JV with BioKangtai to ...